Loading clinical trials...
Loading clinical trials...
This study aims to validate the use of human saliva as a substrate for an assay to detect SARS-CoV-2 and define accuracy, analytical sensitivity and specificity of the TaqPath RT-PCR test.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ambry Genetics
Collaborators
NCT04376034 · COVID19, Coronavirus Infection, and more
NCT05284097 · Virus Diseases, Hemorrhagic Fever, Ebola, and more
NCT04772469 · Human Immunodeficiency Virus, Acquired Immunodeficiency Syndrome, and more
NCT04380701 · Infections, Respiratory, Virus Diseases, and more
NCT04476979 · Coronavirus Infection, SARS (Severe Acute Respiratory Syndrome), and more
Ambry Genetics
Aliso Viejo, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions